Clinical Trial Update: Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure [Phase 2]

View source ↗

Summary

Phase 2 results from Tehran University of Medical Sciences evaluate spironolactone in combination therapy for reducing proteinuria, preserving kidney function, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Essential Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Type 2 Diabetes Mellitus, Diabetic Nephropathy | Phase 2 | Status: COMPLETED